Adial Pharmaceuticals, Inc.: A Biopharmaceutical Company in the Healthcare Sector
Overview
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product, AD04, is a serotonin-3 antagonist that is currently in Phase III clinical trials for the treatment of alcohol use disorder. In addition to this, Adial Pharmaceuticals is also working on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company, founded in 2010 and headquartered in Charlottesville, Virginia, has 16 full-time employees.
Support authors and subscribe to content
This is premium content. Subscribe to read the entire article.
Login if you have purchased
